ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

GERALD TURLO MD

UNIVERSITY HEALTH CENTER STE 5B 4201 ST ANTOINE

Detroit | Michigan | 48201

(888) 264-0102

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,734Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 103

$524K Total Retail Price of All Prescriptions

Rank: 21 out of 103

429 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 429 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

1% of this provider’s 8,057 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
AMLODIPINE BESYLATE 484 460 1 5
SIMVASTATIN 366 352 2 1
LISINOPRIL 301 273 3 2
OMEPRAZOLE 238 189 4 7
LEVOTHYROXINE SODIUM 233 212 5 4
METOPROLOL TARTRATE 227 205 6 8
HYDROCODONE-ACETAMINOPHEN 218 201 S3 7 3
METOPROLOL SUCCINATE 206 203 8 17
FUROSEMIDE 202 193 9 6
METFORMIN HCL 197 176 10 14
HYDROCHLOROTHIAZIDE 186 179 11 15
LOSARTAN POTASSIUM 135 131 12 23
PANTOPRAZOLE SODIUM 134 107 13 37
ISOSORBIDE MONONITRATE ER 123 123 14 26
CRESTOR 121 107 15 66
POTASSIUM CHLORIDE 120 120 16 12
DILTIAZEM 24HR ER 111 108 17 107
ATORVASTATIN CALCIUM 111 107 17 21
TRAMADOL HCL 108 103 19 20
ACETAMINOPHEN-CODEINE 107 95 S3 20 52
DONEPEZIL HCL 104 104 21 11
GLIPIZIDE 101 100 22 40
PROAIR HFA 100 91 23 33
CLOPIDOGREL 97 82 24 28
WARFARIN SODIUM 92 87 25 9
RANITIDINE HCL 88 63 26 31
PRAVASTATIN SODIUM 88 84 26 27
CARVEDILOL 84 76 28 22
NAMENDA 81 81 29 16
GABAPENTIN 80 74 30 13
HYDRALAZINE HCL 79 79 31 34
GLIMEPIRIDE 74 71 32 64
ADVAIR DISKUS 69 66 33 43
CHLORTHALIDONE 68 64 34 128
ZOLPIDEM TARTRATE 66 64 35 35
ENALAPRIL MALEATE 62 61 36 67
SERTRALINE HCL 56 51 37 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 53 38 58
ACTOS 51 51 39 209
PLAVIX 51 48 39 44
CITALOPRAM HBR 50 50 41 10
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.